CDC25A and breast carcinoma: CDC25A is of particular interest since it is a well-characterized oncogene promoting cell cycle progression in cancer cells [108,109,110] and because miR-21 was already previously shown to restrain carcinogenesis in colon and breast cancer, in part by repressing the expression of this specific oncogene [56,57].